SCHEMBL754438

SCHEMBL754438

COc1c(C(=O)N(N)C(=O)Cc2ccc(F)cc2)nc2ccccc2c1OC

nearest known ligand 0.43

Predicted protein targets (top 14)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 2/20 0.43
TACR3 P29371 2/20 0.41
NUDT1 P36639 1/20 0.40
POLB P06746 1/20 0.39
CXCR3 P49682 3/20 0.39
RAB9A P51151 1/20 0.38
LMNA P02545 1/20 0.38
IDO1 P14902 1/20 0.38
TOP2A P11388 2/20 0.38
TOP2B Q02880 2/20 0.38
KDM4E B2RXH2 1/20 0.37
MEN1 O00255 1/20 0.37
HTT P42858 1/20 0.37
KMT2A Q03164 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16925510 0.77 ALDH1A1 (0.52) ALDH1A1POLBRAB9ALMNAKDM4E
SCHEMBL3557026 0.72 PTGER4 (0.39) TACR3LMNAKDM4EMEN1KMT2A
SCHEMBL752046 0.70 POLB (0.53) ALDH1A1TACR3POLBKDM4E
SCHEMBL753481 0.69 POLB (0.51) ALDH1A1POLBLMNAKDM4EMEN1
SCHEMBL825960 0.66 PTGS1 (0.38) ALDH1A1POLBRAB9ALMNAKDM4E
SCHEMBL17921816 0.66 POLB (0.50) ALDH1A1TACR3POLBKDM4E
SCHEMBL1332816 0.64 POLB (0.50) ALDH1A1TACR3POLBRAB9ALMNA
SCHEMBL3087952 0.63 APP (0.48) NUDT1KMT2A
SCHEMBL9061013 0.63 CES2 (0.48) ALDH1A1RAB9AMEN1KMT2A
SCHEMBL6625005 0.63 TDP1 (0.59) ALDH1A1POLBLMNAKDM4EHTT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2266958-B1 Antiviral agent SHIONOGI & CO (JP) 2017-03-15 EP disclosed
US-20170066754-A1 ANTIVIRAL AGENT SHIONOGI & CO., LTD. (JP) 2017-03-09 US disclosed
US-9572813-B2 Antiviral agent SHIONOGI & CO., LTD. (JP) 2017-02-21 US disclosed
EP-3042894-A1 ANTIVIRAL AGENT SHIONOGI & CO., LTD. (JP) 2016-07-13 EP disclosed
US-20150202208-A1 ANTIVIRAL AGENT SHIONOGI & CO., LTD. (JP) 2015-07-23 US disclosed
EP-1422218-B1 ANTIVIRAL AGENT SHIONOGI & CO (JP) 2012-03-21 EP disclosed
EP-2181985-B1 Antiviral Agent SHIONOGI & CO (JP) 2011-10-26 EP disclosed
EP-2181985-A1 Antiviral Agent SHIONOGI & CO., LTD. (JP) 2010-05-05 EP disclosed
US-20040229909-A1 Antiviral agent SHIONOGI & CO., LTD. (JP) 2004-11-18 US disclosed
EP-1422218-A1 ANTIVIRAL AGENT SHIONOGI & CO., LTD. (JP) 2004-05-26 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040229909-A1 Antiviral agent ZC3HAV1, ZC3HAV1L, DUT ALDH1A1 658/4885TACR3 4258/4885NUDT1 178/4885
US-20150202208-A1 ANTIVIRAL AGENT ZC3HAV1, ZC3HAV1L, CCNI ALDH1A1 424/4885TACR3 4228/4885NUDT1 197/4885
US-20170066754-A1 ANTIVIRAL AGENT ZC3HAV1, ZC3HAV1L, CCNI ALDH1A1 424/4885TACR3 4228/4885NUDT1 197/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.